A Research Study on How Well Concizumab Works for You if You Have Haemophilia A or B With or Without Inhibitors
← catalyst calendarSponsored by Novo Nordisk A/S (industry) · NVO — their whole pipeline →.
Phase
Phase 3
Status
Active, not recruiting
Study type
Interventional
Design
Non randomized · None · Treatment
Enrollment
153estimated
Sites
91
Countries
Algeria, Bosnia and Herzegovina, Bulgaria +21
Every value on this page is a field the sponsor filed with ClinicalTrials.gov, reproduced. Dates are their own estimates, revised as a study runs, unless the registry marks them actual. sources →
Source: ClinicalTrials.gov, retrieved 2026-08-19
Dates
each axis at the precision it was filed, with the registry's own basis| Date | Filed | Basis | What it is |
|---|---|---|---|
| Start | 2022-03-24 | actual | When the study began enrolling |
| Primary completion | 2026-04-21 | actual | The date the last participant is measured for the primary outcome — the readout window |
| Study completion | 2029-11-02 | estimated | The whole study's end, after follow-up |
| First posted | 2021-11-26 | actual | When this record first appeared on the registry |
| Results posted | — | When the sponsor posted results to the registry | |
| Record updated | 2026-08-13 | actual | The sponsor's own last edit to this record — every projection above is as current as this date |
What it studies
Condition
- Haemophilia A and B With and Without Inhibitors
Intervention
- Drug: Concizumab
Primary outcomes
what the primary-completion date above is the date OFFor inhibitor patients with at least 26 weeks on-demand treatment during the last 52 weeks prior enrolment: Number of treated spontaneous and traumatic bleeding episodes
measured From start of treatment (week 0) up until the primary analysis cut-off (at least 32 weeks)
For non-inhibitor patients treated on demand during at least the last 52 weeks prior enrolment: Number of treated spontaneous and traumatic bleeding episodes
measured From start of treatment (week 0) up until the primary analysis cut-off (at least 32 weeks)
Permalink · NVO's whole pipeline · Catalyst calendar · Every registered study · What changed